260 related articles for article (PubMed ID: 7279343)
1. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.
Gordon A; Lipton D; Woodruff JD
Obstet Gynecol; 1981 Oct; 58(4):497-504. PubMed ID: 7279343
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 57 patients with ovarian dysgerminoma].
Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
[TBL] [Abstract][Full Text] [Related]
3. [Ovarian dysgerminoma in children and adolescents. Retrospective clinico-pathologic study].
Zuntová A; Sumerauer D; Teslík L; Koutecký J
Cas Lek Cesk; 2004; 143(4):246-52. PubMed ID: 15218724
[TBL] [Abstract][Full Text] [Related]
4. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
8. [Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy].
Dilhuydy JM; Lagarde P; Chauvergne J; Mongodin B; Dilhuydy MH; Coindre JM; Avril A; Richaud P; Pigneux J
Bull Cancer; 1990; 77(3):213-24. PubMed ID: 2340352
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
[TBL] [Abstract][Full Text] [Related]
11. Dysgerminoma of the ovary.
LaPolla JP; Benda J; Vigliotti AP; Anderson B
Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of pure stage one ovarian dysgerminoma in young women. Report of a case and review of the literature].
Mazza D; Pozzi M; Sedati A; Vocaturo G
Minerva Ginecol; 1999; 51(1-2):27-30. PubMed ID: 10230241
[TBL] [Abstract][Full Text] [Related]
13. [Dysgerminoma of the ovary: a clinical retrospective analysis of 60 cases].
Zhang R; Hong W; Li S
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):550-2. PubMed ID: 8556917
[TBL] [Abstract][Full Text] [Related]
14. [Dysgerminoma of the ovary--a clinical report of 27 patients].
Hou YJ; Liu LY
Zhonghua Zhong Liu Za Zhi; 1987 Jul; 9(4):311-4. PubMed ID: 3678024
[TBL] [Abstract][Full Text] [Related]
15. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
16. Ovarian germinomas (dysgerminomas).
Burkons DM; Hart WR
Obstet Gynecol; 1978 Feb; 51(2):221-4. PubMed ID: 622236
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological study of malignant ovarian germ cell tumor].
Kataoka A; Yakushiji M; Nishida T; Oda T; Kojiro M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):695-701. PubMed ID: 2549132
[TBL] [Abstract][Full Text] [Related]
18. Dysgerminoma: the role of conservative surgery.
Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
[TBL] [Abstract][Full Text] [Related]
19. Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Scollo P; Viganò R; Gamucci T; Candiani M; Pignata S
Gynecol Oncol; 2011 May; 121(2):280-4. PubMed ID: 21277010
[TBL] [Abstract][Full Text] [Related]
20. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
